US Pharma & Biotech Neuroscience - PPC Market Share Analysis October 2026

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Neuroscience category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Neuroscience – US

Google AI Overview visibility for Pharma & Biotech Neuroscience US

See how often AIOs appear and how search intent is distributed across buying signals.

AIO Frequency

How often a Google AI overview appears on search terms relevant to this category.

Frequency Percentage
Frequency 67.9167024843
32.0832975157
67%

Complex Query Frequency

A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.

Frequency Percentage
Frequency 31
69
31%

Search Intent Distribution

Breakdown of search queries by their underlying goal.

Intent Distribution
Investigational 8%
Transactional 4%
Navigational 1%
Seasonal 0%
Local 0%
Problem Solving 30%

Copyright © Adthena. All rights reserved.

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Neuroscience brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

Share of Clicks - Last month
Share of Clicks - Last month
Domain Share of clicks
vraylar.com 30.27
rexulti.com 22.97
caplyta.com 12.69
rexultihcp.com 6.07
nurtec.com 4.39
caplytahcp.com 3.01
vraylarhcp.com 2.85
vyepti.com 2.8
spravato.com 1.83
cobenfy.com 1.13
others 11.99
  • vraylar.com - 30.27%
  • rexulti.com - 22.97%
  • caplyta.com - 12.69%
  • rexultihcp.com - 6.07%
  • nurtec.com - 4.39%
  • caplytahcp.com - 3.01%
  • vraylarhcp.com - 2.85%
  • vyepti.com - 2.8%
  • spravato.com - 1.83%
  • cobenfy.com - 1.13%
  • others - 11.99%

Copyright © Adthena. All rights reserved.

In the PPC landscape, vraylar.com leads with 30.27% click share, followed by rexulti.com at 22.97%. ‘Others’ collectively hold 11.99%, showcasing diverse competition.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Neuroscience brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month. 

Share of Spend - Last Month
Share of Spend - Last Month
Date vraylar.com caplyta.com rexulti.com caplytahcp.com rexultihcp.com nurtec.com vraylarhcp.com vyepti.com cobenfy.com spravato.com
2026/10/01 28.55% 22.6% 13.29% 6.54% 8.26% 1.65% 4.47% 2.42% 0.66% 1.11%
2026/10/02 29.82% 18.59% 15.06% 7.63% 7.33% 1.75% 4.39% 1.91% 1.17% 1.26%
2026/10/03 28.37% 22.42% 13.78% 6.29% 7.53% 1.51% 3.17% 1.62% 1.1% 1.78%
2026/10/04 27.89% 21.03% 13.92% 6.78% 7.58% 1.35% 3.16% 1.6% 1.15% 1.85%
2026/10/05 29.52% 21.78% 13.96% 4.57% 7.55% 1.74% 4.08% 1.88% 1.08% 1.4%
2026/10/06 29.15% 21.79% 14.22% 5.61% 7.07% 2.01% 3.66% 2.4% 1.04% 1.64%
2026/10/07 32.01% 20.16% 14.98% 3.72% 8.4% 2.08% 4.44% 1.65% 0.99% 2.45%
2026/10/08 35.24% 10.81% 17.5% 2.31% 9.03% 2.08% 4.57% 2.4% 0.82% 2.54%
2026/10/09 32.02% 15.77% 14.35% 4.94% 8.12% 2.68% 3.62% 2.03% 1.11% 3.03%
2026/10/10 34.14% 15.62% 14.51% 3.34% 7.61% 3.34% 3.29% 2.4% 1.14% 3.25%
2026/10/11 31.26% 17.33% 14.35% 4.68% 9.07% 2.16% 1.51% 2.08% 1.01% 3.09%
2026/10/12 32.03% 13.3% 14.87% 2.92% 9.21% 2.6% 3.52% 2.26% 0.89% 2.99%
2026/10/13 31.33% 8.78% 15.4% 3.38% 9.28% 3.96% 3.66% 3.49% 1.21% 2.07%
2026/10/14 32.32% 8.61% 16.49% 3.58% 8.22% 3.49% 3.92% 2.76% 1.09% 2.45%
2026/10/15 34.41% 6.93% 17.86% 3.99% 8.25% 3.57% 3.15% 2.3% 1.15% 2.67%
2026/10/16 32.67% 9.5% 17.42% 3.24% 8.69% 3.07% 3.26% 2.53% 1.1% 3.78%
2026/10/17 30.92% 14.3% 17.99% 3.57% 7.82% 3.82% 3.22% 2.57% 0.96% 3.53%
2026/10/18 29.47% 12.69% 17.92% 4.22% 7.58% 4.74% 3.58% 3.09% 1.05% 3.04%
2026/10/19 29.59% 11.73% 18.45% 2.76% 7.89% 4.2% 5.35% 2.74% 1.39% 1.91%
2026/10/20 30.13% 15.59% 18.62% 2.02% 7.89% 3.79% 4.09% 2.85% 1.3% 2.16%
2026/10/21 28.9% 21.95% 16.91% 1.94% 7.11% 2.69% 4.1% 2.09% 1.35% 1.81%
2026/10/22 26.82% 21.93% 16.72% 3.41% 6.68% 3.96% 4.81% 2.06% 1.19% 1.88%
2026/10/23 25.91% 19.32% 18.09% 3.66% 7.65% 4.57% 3.68% 2.04% 0.97% 2.19%
2026/10/24 26.44% 19.04% 17.28% 3.44% 7.41% 4.53% 3.51% 1.79% 1.16% 2.8%
2026/10/25 25.75% 20.21% 15.58% 6.16% 6.49% 4.59% 3.31% 2.48% 1.16% 2.48%
2026/10/26 27.61% 22.96% 16.2% 2.71% 7% 3.31% 4.43% 2.18% 1.11% 2.66%
2026/10/27 26.34% 21.11% 16.72% 1.44% 7.15% 4.52% 4.67% 2.88% 1.35% 1.36%
2026/10/28 27.74% 21.72% 15.36% 5.46% 6.37% 3.74% 4.56% 2.6% 1% 1.43%
2026/10/29 25.83% 19.82% 16.27% 5.4% 6.57% 4.51% 4.76% 2.39% 1.05% 0.98%
2026/10/30 27.39% 19.97% 18.15% 6.9% 7.21% 4.29% 3.17% 1.94% 1.18% 0.95%
2026/10/31 28.69% 20.15% 13.07% 6.62% 5.4% 4.06% 3.22% 2.85% 0.42% 0.32%
  • vraylar.com
  • caplyta.com
  • rexulti.com
  • caplytahcp.com
  • rexultihcp.com
  • nurtec.com
  • vraylarhcp.com
  • vyepti.com
  • cobenfy.com
  • spravato.com

Copyright © Adthena. All rights reserved.

In October 2026, Vraylar.com led with a peak spend share of 35.24% on October 8. Caplyta.com fluctuated, starting at 22.60% and ending at 20.15%. Rexulti.com showed steady growth, peaking at 18.62% on October 20.

Market Exposure

Competitor Count for US Pharma & Biotech Neuroscience

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month. 

Competitor Count - Last month
Competitor Count - Last month
Date Competitor Count
2026/10/01 78
2026/10/02 75
2026/10/03 76
2026/10/04 74
2026/10/05 80
2026/10/06 80
2026/10/07 70
2026/10/08 77
2026/10/09 72
2026/10/10 76
2026/10/11 76
2026/10/12 81
2026/10/13 84
2026/10/14 79
2026/10/15 82
2026/10/16 84
2026/10/17 82
2026/10/18 83
2026/10/19 84
2026/10/20 79
2026/10/21 81
2026/10/22 80
2026/10/23 73
2026/10/24 78
2026/10/25 79
2026/10/26 75
2026/10/27 77
2026/10/28 75
2026/10/29 75
2026/10/30 75
2026/10/31 75

Copyright © Adthena. All rights reserved.

October began with 78 advertisers, fluctuating throughout the month. Peaks reached 84, while lows hit 70. The month concluded with a steady 75 advertisers.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Neuroscience

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

Market Loss & Market Gains - Last month
Market Loss & Market Gains - Last month
Name Market Trend
caplyta.com 3.04%
rexulti.com 2.84%
nurtec.com 1.56%
qulipta.com 0.47%
vraylarhcp.com 0.38%
spravato.com -0.64%
spravatohcp.com -0.82%
goodrx.com -1.01%
rexultihcp.com -1.18%
vraylar.com -4.39%

Copyright © Adthena. All rights reserved.

Caplyta.com surged with a 3.04% click share increase, while vraylar.com faced a significant drop of 4.39%. Rexulti.com and nurtec.com also saw positive gains, contrasting with declines for rexultihcp.com and goodrx.com.

Campaign Efficiency

US Pharma & Biotech Neuroscience Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

Date vraylar.com caplyta.com rexulti.com rexultihcp.com caplytahcp.com nurtec.com vyepti.com vraylarhcp.com abilifyasimtufii.com spravato.com
2026/10/01 15.96% 11.95% 12.26% 12.58% 8.74% 2.47% 6.02% 7.17% 1.48% 2.11%
2026/10/02 15.71% 11.02% 13.03% 11.59% 9.12% 2.51% 4.42% 7.41% 3.07% 2.66%
2026/10/03 15.27% 13.17% 12.26% 12.13% 7.78% 2.26% 3.55% 4.99% 2.89% 3.44%
2026/10/04 15.05% 12.51% 12.49% 12.1% 8.08% 1.67% 3.79% 5.02% 2.9% 3.7%
2026/10/05 15.91% 13.45% 12.65% 12.22% 5.72% 2.28% 4.33% 6.83% 2.29% 2.81%
2026/10/06 15.53% 13.46% 12.79% 11.78% 6.69% 2.8% 5.68% 6.65% 2.49% 3.09%
2026/10/07 16.93% 11.59% 13.89% 13.59% 4.57% 3.03% 3.38% 8.15% 2.42% 4.73%
2026/10/08 17.61% 8.02% 14.43% 13.34% 2.6% 2.7% 5.17% 7.81% 2.64% 4.64%
2026/10/09 16.39% 9.01% 12.31% 12.56% 5.77% 3.93% 4.38% 6.27% 2.55% 5.66%
2026/10/10 17.01% 9.98% 12.72% 11.57% 4.13% 5.02% 5.21% 6.08% 1.93% 6.11%
2026/10/11 15.72% 10.31% 13.37% 13.95% 5.82% 3.04% 4.68% 3.05% 2.39% 5.63%
2026/10/12 15.3% 9.03% 12.26% 13.7% 3.51% 3.33% 4.77% 6.14% 2.35% 5.07%
2026/10/13 14.53% 5.53% 11.98% 12.85% 3.81% 5.34% 7.24% 6% 1.15% 3.78%
2026/10/14 15.02% 6.16% 12.6% 11.76% 4.29% 4.57% 5.59% 6.73% 2.39% 4.08%
2026/10/15 16.25% 5.93% 14.07% 12.01% 4.6% 4.85% 4.64% 5.28% 2.23% 4.49%
2026/10/16 16.39% 5.88% 13.5% 13.42% 4.26% 4.34% 5.68% 5.82% 2.17% 6.42%
2026/10/17 16.32% 9.08% 13.91% 12.16% 4.4% 6.07% 5.68% 5.92% 2.74% 6.63%
2026/10/18 14.33% 8.54% 12.77% 11.26% 5.01% 7.5% 6.79% 6.12% 3.01% 5.65%
2026/10/19 15.42% 6.96% 13.59% 12.16% 3.5% 6.44% 6.07% 8.6% 2.99% 3.33%
2026/10/20 16.63% 8.4% 14.39% 12.86% 2.89% 5.9% 6.69% 7.39% 2.58% 4.25%
2026/10/21 16.36% 11.22% 13.69% 12.03% 2.91% 4.02% 5.83% 7.85% 2.74% 3.61%
2026/10/22 15.49% 11.98% 12.63% 10.83% 4.58% 6.7% 5.06% 8.63% 2.54% 3.83%
2026/10/23 13.83% 10.53% 14.22% 12.36% 4.57% 7.61% 4.61% 6.88% 2.2% 4.44%
2026/10/24 14.19% 10.53% 13.88% 11.54% 4.29% 7.33% 3.9% 6.16% 2.52% 5.09%
2026/10/25 14.4% 10.56% 11.68% 9.96% 7.8% 7.75% 5.46% 6.01% 3.13% 4.68%
2026/10/26 16.08% 12.55% 13.61% 11.58% 3.48% 5.73% 5.43% 8.13% 2.44% 5.26%
2026/10/27 15.41% 11.14% 13.34% 11.22% 1.89% 7.78% 6.67% 8.04% 2.37% 2.46%
2026/10/28 15.92% 11.87% 12.43% 10.44% 7.13% 6.43% 6.03% 7.67% 2.89% 2.83%
2026/10/29 14.12% 10.85% 12.8% 10.9% 6.65% 7.73% 5.45% 8.29% 1.85% 1.93%
2026/10/30 16.35% 11.73% 14.54% 12.16% 8.7% 7.34% 4.57% 5.99% 2.1% 1.96%
2026/10/31 15.83% 11.09% 9.92% 8.68% 7.87% 6.85% 6.69% 5.9% 1.17% 0.6%
  • vraylar.com
  • caplyta.com
  • rexulti.com
  • rexultihcp.com
  • caplytahcp.com
  • nurtec.com
  • vyepti.com
  • vraylarhcp.com
  • abilifyasimtufii.com
  • spravato.com

Copyright © Adthena. All rights reserved.

In October 2026, Vraylar.com led with fluctuating impressions, peaking mid-month. Caplyta.com saw a dip, while Rexulti.com maintained steady growth. Nurtec.com and Vyepti.com showed consistent gains, ending the month strong.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Neuroscience

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Neuroscience - Last month
  1. 1
    CAPLYTA® (lumateperone) - Official Patient Website https://www.caplyta.com/

    Visit the Official Site for Product & Safety Information, Including Boxed WARNINGS. Find Out Information On CAPLYTA® & How To Talk To Your Doctor About Add-On Therapy Option.

  2. 2
    Treat Migraine Attacks - Oral Migraine Medication

    Learn More About A Migraine Treatment Option. Acute & Preventive Info.

  3. 3
    REXULTI® (brexpiprazole) - FDA-Approved Treatment Option https://www.rexulti.com/

    REXULTI® (brexpiprazole) Important Safety, Prescribing Info & Boxed Warning

  4. 4
    VRAYLAR® (cariprazine) - Medication Information https://www.vraylar.com/

    See VRAYLAR® (cariprazine) Full Prescribing Information, Including Boxed Warnings.

  5. 5
    Migraine Medication - FDA-Approved Medication

    Frustrated by migraine days? Consider another treatment option.

Copyright © Adthena. All rights reserved.

In the competitive landscape of pharmaceuticals, top-performing Google PPC ads reveal a focus on safety and informed decision-making. CAPLYTA® emphasizes patient education and doctor discussions, while REXULTI® and VRAYLAR® highlight FDA approval and safety warnings. Migraine treatments like Nurtec and Vyepti offer alternative solutions, addressing patient frustrations.

Frequently Asked Questions

Customer Success Stories

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.